Return to homepagePandemic Pact

COVID-19 Therapeutics II: Inhaled anti-miR against COVID-19-induced inflammatory lung injury (CoVmiR) - clinical study

  • Funded by Federal Ministry of Research, Technology and Space (BMFTR)
  • Total publications:0 publications

Grant number: 03LW0153

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2021
    2024

  • Known Financial Commitments (USD)

    $395,891.61

  • Funder

    Federal Ministry of Research, Technology and Space (BMFTR)

  • Principal Investigator

    N/A

  • Research Location

    Germany

  • Lead Research Institution

    LungenClinic Grosshansdorf GmbH

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Unspecified

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

N/A